Unknown compound identification | Materials Metric
Unknown compound identification turns mystery peaks into named structures. Materials Metric explains the analytical workflow behind it.
READ MOREUnknown compound identification turns mystery peaks into named structures. Materials Metric explains the analytical workflow behind it.
READ MOREChoosing the right extraction conditions makes or breaks an E&L study. Materials Metric explains how to select solvents, time, and…
READ MOREExhaustive extraction captures the worst-case chemical profile of a device. Materials Metric explains when it beats simulated-use extraction.
READ MOREMedical device extractables and leachables studies reveal what migrates from your materials. Materials Metric explains how E&L testing works.
READ MOREExtractables vs leachables: what is the real difference and why it matters. Materials Metric explains how each study supports device…
READ MOREKnow your 510k testing requirements before you submit. Materials Metric outlines the data FDA expects for a clean premarket review.
READ MOREA supplier change risk assessment protects you when materials shift. Materials Metric explains how to evaluate impact on device safety.
READ MOREA material change biocompatibility re-evaluation is often required after substitutions. Materials Metric explains what triggers new testing.
READ MOREChemical characterization vs biocompatibility testing: which does your device need? Materials Metric explains how the two approaches work together.
READ MOREReusable medical device testing must account for cumulative exposure. Materials Metric explains how reprocessing changes biocompatibility needs.
READ MORE